Work

Supplementary Figure S2 from Pilot Study of Daily Exemestane in Women with Endometrial Intraepithelial Neoplasia or Low-Grade Endometrial Cancer

Year: 2025

Type: supplementary-materials

Abstract: A: Comparison of serum estradiol levels vs BMI at baseline (pre-treatment) (p = 0.001). B: Serum estradiol vs BMI at surgery (post-treatment) (p = 0.0004) C: Change in serum estradiol vs BMI (p = 0.86)

DOI: 10.1158/1078-0432.30750270

Authors: Britt K. Erickson, Howard Bailey, Rebecca C. Arend, Dina El-Rayes, Mahmoud A. Khalifa, Amy Skubitz, Kristin Boylan, Andrew C. Nelson, Anna Burton, Bharat Thyagarajan, Thomas Havighurst, KyungMann Kim, Eileen Dimond, Katina DeShong, Brandy Heckman-Stoddard, Goli Samimi, Eva Szabo, Lisa Barroilhet

Topic: Endometrial and Cervical Cancer Treatments

Subfield: Obstetrics and Gynecology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4416844871

Cites:

Cited by:

Related to: